Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.56 USD
Change Today -0.0128 / -2.22%
Volume 635.6K
KBIO On Other Exchanges
Symbol
Exchange
NASDAQ GM
Stuttgart
As of 8:10 PM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Dan Shochat Ph.D.

Head of Non-Clinical Development and Vice President, KaloBios Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 35 board members in 4 different organizations across 8 different industries.

See Board Relationships
74--

Background*

Dr. Dan Shochat, Ph.D., has been a Vice President of Non-Clinical Development at KaloBios Pharmaceuticals Inc. (Formerly Kalobios Inc.) since January 2004. Dr. Shochat serves as a Scientific Advisor at Marillion Pharmaceuticals Inc. He served as a Consulting Vice President and Vice President at Intellect Neurosciences, Inc. Dr. Shochat served as the President of Non-Clinical Development at KaloBios Therapeutics. He served as Executive Vice President of Development of ...

Read Full Background

Corporate Headquarters*

442 Littlefield Avenue
South San Francisco, California 94080

United States

Phone: 650-243-3100
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MS 1968
Hebrew University of Jerusalem
BS 1965
Hebrew University of Jerusalem
PhD 1976
L S U Medical School In New Orleans

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KBIO:US $0.56 USD -0.0128

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KALOBIOS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.